Charles Schwab Investment Management Inc Humacyte, Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Humacyte, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 473,767 shares of HUMA stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
473,767
Previous 491,257
3.56%
Holding current value
$2.27 Million
Previous $1.4 Million
5.59%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HUMA
# of Institutions
100Shares Held
23.1MCall Options Held
67.8KPut Options Held
198K-
Black Rock Inc. New York, NY4.79MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$19.3 Million0.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.16MShares$10.3 Million2.7% of portfolio
-
Sio Capital Management, LLC New York, NY2MShares$9.6 Million2.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.35MShares$6.48 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $494M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...